If I understand the current $$s Theralase has approx 1 to 1.5 years of cash , ( laser sales being the spread here IMHO ) If you recall these warrants were extended. I am not sure if we have other warrants coming due before this date however It would appear we will not have the funds available to go it alone on another 2 indications without partners. Certainly Covid has like many companies hit TLT hard , The theraputic laser is a Tribute to Rodgers contributions and it does work , Wider distribution of the TLC 2000 would help the balance sheets , I know from experience how the TLC 2000 helps clincally.Hopefully the 3200 will do well as we move fwd with Trials. Does anyone recall if we have and are waiting for FDA approval in US for trating more than just Knees ?
TORONTO, ON / ACCESSWIRE /January 8, 2021 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug formulations intended to safely and effectively destroy various cancers, announces that the Company proposes to extend the expiry date of 4,095,157 share purchase warrants, all of which are exercisable at $0.50 per share (collectively, the "Warrants").
The Warrants were issued on January 9, 2019 pursuant to a private placement involving the issuance of 4,095,157 units of the Company. The Company proposes to extend the expiry date of the Warrants that remain outstanding from the original expiry date of January 9, 2021 to January 9, 2023.
All other terms and conditions of the Warrants will remain unchanged. The Warrant expiry date extension is subject to final acceptance by the TSX Venture Exchange.